Labelling compliance review
A label carrying every mandatory particular can still mislead. We review its compliance and how consumers and the enforcement authority in the country of sale will read it.
Labelling, food safety, commercial communication, scientific evidence and access to the internal market: the dimensions that determine how a food product can be positioned, and the ones from which we analyse every case.
Scope and fee agreed from the first contact, support at any stage of the procedure, and collaboration with specialists through signed opinions. This is how every opinion is built.
Monitoring of the developments with the greatest practical impact on the sector, with an assessment of what they mean for operators.
For operators established outside the Union who intend to place food products or food supplements on the EU market.
The substantive rules on product status, labelling and commercial communication are largely harmonised, so one analysis serves the whole internal market. Enforcement, however, remains national. We analyse the EU framework together with its application in Spain; where a case calls for another national layer, we work with local specialists.
A label carrying every mandatory particular can still mislead. We review its compliance and how consumers and the enforcement authority in the country of sale will read it.
A health claim that is not authorised in the Union Register, or that departs from its conditions of use, is prohibited in every Member State.
A complete campaign — visuals, context and channel — can contain infringements that no single claim reveals when assessed in isolation.
Launching an ingredient without first establishing its status under Regulation (EU) 2015/2283 may force the withdrawal of products already manufactured.
A misclassified botanical can turn a food supplement into an unauthorised medicinal product in the eyes of a national medicines authority.
Directive (EU) 2024/825 sets 27 September 2026 as the date of application of its prohibitions on generic environmental claims, claims based on emissions offsetting and sustainability labels not based on a certification scheme.
For operators established in the EU who already market their products in another Member State and are extending distribution to Spain.
Before relying on mutual recognition to sell in Spain a product lawfully marketed in another Member State, test whether the case will hold: a full procedure built on a weak case can mean months lost to a refusal.
Strategic advice and drafting of submissions throughout the administrative procedure before the Spanish authorities, from the response to the initiation decision to the administrative appeal (recurso de alzada).
Analyses based exclusively on verified primary sources: EUR-Lex, the Spanish Official Gazette (BOE) and the Spanish Agency for Food Safety and Nutrition (AESAN). No commercial noise; academic rigour, applied.

The General Court annulled the 2021 prohibition, but the Commission is already preparing a new measure without waiting for the outcome of the appeal.

An extract's fate is not decided in the laboratory, but by the procedural channel it is in.

The sector's instinctive response to a restriction is to generate science: the route whose return is least well documented.

The threshold at which maximum levels are set is not a neutral technical choice, but the factor that will decide which products move freely in the Union.

The practical question is not whether the Directive will reach the sector once it is transposed, but whether today's labels would withstand scrutiny under food law itself.

According to the Commission guidance, sales packaging is placed on the market when it is filled: packaging bought empty before 12 August 2026 is not covered.
Describe your regulatory need in 60 seconds and receive a standardised quote with a defined scope and timeline.
Subscription models reserved for clients with an active product portfolio.
Regulatory monitoring tailored to your product categories. Qualified alerts and impact analysis on your active portfolio, not generic newsletters.
Periodic review of your product portfolio to make sure regulatory changes do not open new compliance gaps.